首页> 外文OA文献 >Phase I Study of Ofatumumab, a Human Anti-CD20 Antibody, in Japanese Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

【2h】

Phase I Study of Ofatumumab, a Human Anti-CD20 Antibody, in Japanese Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

机译：在日本患者复发或难治性慢性淋巴细胞白血病和小淋巴细胞淋巴瘤中的人抗CD20抗体，人抗CD20抗体的研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Michinori Ogura; Kiyohiko Hatake; Kensei Tobinai; Toshiki Uchida; Tatsuya Suzuki; Yasuhito Terui; Masahiro Yokoyama; Dai Maruyama; Masakazu Mori; Roxanne C. Jewell; Koichi Katsura; Tomomitsu Hotta;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 复发性晚期滤泡性淋巴瘤的IDEC-C2B8(利妥希玛)抗CD20抗体治疗:德国低度恶性淋巴瘤研究组Ⅱ期研究结果 [J] . 李登举, 唐锦治中德临床肿瘤学杂志（英文版） . 2001,第004期
2. Phase I study of Ofatumumab, a human anti-CD20 antibody, in Japanese patients with relapsed or refractory chronic lymphocytic leukemia and small lymphocytic lymphoma [J] . OguraM., HatakeK., TobinaiK., Japanese journal of clinical oncology. . 2013,第5期

机译：在日本患有复发性或难治性慢性淋巴细胞性白血病和小淋巴细胞淋巴瘤的日本患者中，ofatumumab（一种人类抗CD20抗体）的I期研究
3. Safety and efficacy of ofatumumab, a fully human monoclonal anti-CD20 antibody, in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: a phase 1-2 study. [J] . Coiffier B, Lepretre S, Pedersen LM, Blood: The Journal of the American Society of Hematology . 2008,第3期

机译：Ofatumumab（一种完全人类单克隆抗CD20抗体）在复发或难治性B细胞慢性淋巴细胞性白血病患者中的安全性和有效性：1-2期研究。
4. Results From the Phase 3 DUO Trial: A Randomized Comparison of Duvelisib Vs Ofatumumab in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [J] . Susan M. O’Brien Clinical advances in hematology & oncology: H&O . 2018,第1Suppla2期

机译：第3阶段Duo试验结果：Duvelisib对患者Duvelisib Vs患者的随机比较患者患者复发/难治性慢性淋巴细胞白血病或小淋巴细胞淋巴瘤
5. Efficiency and Toxmcity of the Fludarabine and Cyclo- Phosphamide Combined Therapy in Relapsed/ Resistant Patients with B-cell Chronic Lymphocytic Leukaemia (CLL)-Polish Multicenter Study [C] . M. Kowal, A. Dmoszynska, D. Jawniak, European Haematology Association . 2002

机译：B-Cell慢性淋巴细胞白血病（CLL） - 渗透多中心研究的复发/抗性患者复发/抗性患者的氟氮胺碱和环磷酰胺联合治疗的效率和毒性
6. Risk Factors for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Incidence in Postmenopausal Women: A Women's Health Initiative (WHI) Study [D] . Maharry, Kati S. 2016

机译：绝经后妇女慢性淋巴细胞白血病和小淋巴细胞淋巴瘤发生率的危险因素：妇女健康倡议（WHI）研究
7. Phase I Study of Ofatumumab a Human Anti-CD20 Antibody in Japanese Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma [O] . Michinori Ogura, Kiyohiko Hatake, Kensei Tobinai, -1

机译：在日本患有复发性或难治性慢性淋巴细胞白血病和小淋巴细胞淋巴瘤的日本患者中ofatumumab（一种人类抗CD20抗体）的I期研究
8. Safety and efficacy of ofatumumab, a fully human monoclonal anti-CD20 antibody, in patients with relapsed or refractory B-cell chronic lymphocytic leukemia:a phase 1-2 study [O] . Coiffier Bertrand, Lepretre Stéphane, Pedersen Lars Møller, 2008

机译：完全人类单克隆抗CD20抗体ofatumumab在复发或难治性B细胞慢性淋巴细胞性白血病患者中的安全性和有效性：1-2期研究

Phase I Study of Ofatumumab, a Human Anti-CD20 Antibody, in Japanese Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

著录项

引文网络

相似文献

相关主题

期刊订阅